𝔖 Bobbio Scriptorium

✦ LIBER ✦

In vivo influenza virus-inhibitory activity of an orally administered neuraminidase inhibitor: R.W. Sidwell1, J.H. Huffman1, K.W. Bailey1, M.H. Wong1 and C.U. Kim2. 1Inst. for Antiviral Research, Utah State Univ., Logan, UT and 2Gilead Sciences, Inc., Foster City, CA, USA.

Book ID: 114145069
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 109 KB
Volume: 34
Category: Article
ISSN: 0166-3542
DOI: 10.1016/s0166-3542(97)83254-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

62 In vivo influenza-inhibitory effects

62 In vivo influenza-inhibitory effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 : R.W. Sidwell1, D. F. Smee1, K. W. Bailey1, J. H. Huffman1, D. L. Barnard1, M.-H. Wong1, K. Bush2 and Y. S. Babu3. 1Inst. for Antiviral Res., Utah State Univ., Logan, UT, USA. 2The R. W. Johnson Pharm. Res. Inst., Raritan, NJ, USA. 3BioCryst Pharmaceuticals Inc., Birmingham, AL, USA

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 130 KB

201 Influenza virus-inhibitory activity

201 Influenza virus-inhibitory activity of a series of antisense oligonucleotides: J. H. Huffman1, R. W. Sidwell1, A. P. Gessaman1, B. J. Moscone1, J. Y. Tang2 and S. Agrawal2. 1Institute for Antiviral Res., Utah State Univ., Logan, UT, USA and 2Hybridon, Inc., Worcester, MA, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB

In vitro and in vivo influenza-inhibitor

In vitro and in vivo influenza-inhibitory effects of a series of polyoxometalates: R. W. Sidwell1, J. H. Huffman1, K. W. Bailey1, A. Gessaman1, M. J. Otto2, C. Hill3 and R. F. Schinazi3. Inst. for Antiviral Res., Utah State Univ., Logan, UT 84322-56001; Avid Therapeutics, Inc., Philadelphia, PA 191042, and VA Medical Ctr.Emory Univ., Decatur, GA 300333, USA

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 68 KB

GS 4104: A highly potent orally bioavail

GS 4104: A highly potent orally bioavailable influenza neuraminidase inhibitor: M.A. Williams1, C. U. Kim1, W. Lew1, L. Zhang1, S. Swaminathan1, N. Bischofberger1, M.S. Chen1, D. Mendel1, W. Li1, L. Tai1, P. Escarpe1, K.C. Cundy1, E.J. Eisenberg1, S. Lacy1, R. W. Sidwell2; R.C. Stevens3, W. G. Laver4. 1Gilead Sciences Inc., 353 Lakeside Dr., Foster City, CA 94404; 2Inst. for Antiviral Res., College of ADVS, Utah State Univ., Logan, UT 84322; 3Dept. of Chem., Univ. of California, Berkeley, CA 94720; 4John Curtin School of Med. Res., Australian Nat'l Univ., Canberra 260, Australia

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 107 KB

61 A new class of cyclopentane derivativ

61 A new class of cyclopentane derivatives with potent inhibitory activity against influenza A and B viruses in cell culture : D.F. Smee1, A.C. Morrison1, J.H. Huffman1, D.L. Barnard1, P.C. Wagaman2, K. Bush3, and R.W. Sidwell1. 1Institute for Antiviral Research, Utah State University, Logan, UT, USA. R.W. Johnson Pharmaceutical Research Institute, La Jolla, CA2 and Raritan, NJ3, USA

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 127 KB